Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms, Unknown Primary × Cisplatin × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Non-Small-Cell Lung 118 Squamous Cell Carcinoma of Head and Neck 70 Lung Neoplasms 46 Head and Neck Neoplasms 38 Urinary Bladder Neoplasms 37 Uterine Cervical Neoplasms 28 Parkinson Disease 4, Autosomal Dominant Lewy Body 28 Biliary Tract Neoplasms 28 Nasopharyngeal Carcinoma 27 Cholangiocarcinoma 26 Oropharyngeal Neoplasms 23 Esophageal Squamous Cell Carcinoma 22 Carcinoma 22 Neoplasm Metastasis 20 Carcinoma, Squamous Cell 20 Neoplasms 19 Ovarian Neoplasms 18 Esophageal Neoplasms 18 Colorectal Neoplasms 18 Carcinoma, Transitional Cell 17 Stomach Neoplasms 15 Mesothelioma, Malignant 15 Gallbladder Neoplasms 15 Small Cell Lung Carcinoma 13 Pancreatic Neoplasms 11 Mouth Neoplasms 11 Laryngeal Neoplasms 11 Hypopharyngeal Neoplasms 10 Breast Neoplasms 10 Melanoma 9

Interventions

pembrolizumab 2 atezolizumab 2 zenocutuzumab 1 sintilimab 1 pertuzumab 1 pemigatinib 1 olaparib 1 ivosidenib 1 ipatasertib 1 entrectinib 1 cobimetinib 1 alectinib 1 Whole Genome Sequencing 1 Vemurafenib 1 Transurethral Resection of Prostate 1 Specimen Handling 1 Sequence Analysis, RNA 1 Radiosurgery 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 HhAntag691 1 Genetic Testing 1 Genetic Profile 1 Gemcitabine 1 Fluorodeoxyglucose F18 1 FAPI-46 1 Erlotinib Hydrochloride 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03498521 2025-11-19

CUPISCO

Hoffmann-La Roche

Phase 2 Completed

529 enrolled 16 charts

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡